Effect of soya protein on serum lipid profile and lipoprotein concentrations in patients undergoing hypercholesterolaemic haemodialysis

Shu Tzu Chen, Jiun-Rong Chen, Chwei Shiun Yang, Sheng Jeng Peng, Shyang H. Feng

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Clinical trials have shown that soya protein reduces the concentrations of some atherogenic lipids in subjects with normal renal function. The present study examined the effects of soya protein on serum lipid concentrations and lipoprotein metabolism in patients on hypercholesterolaemic haemodialysis. Twenty-six hypercholesterolaemic (total cholesterol ≥ 6.21 mmol/l) patients on haemodialysis were studied in a randomized, double-blind, placebo-controlled clinical trial. After a 4-week run-in phase, the subjects were randomly assigned to two groups. Isolated soya protein or milk protein 30g was consumed daily as a beverage at breakfast or post-dialysis for 12 weeks. Soya protein substitution resulted in significant reductions in total cholesterol (17.2 (SD 8.9)%), LDL-cholesterol (15.3 (SD 12.5)%), apo B (14.6 (SD 12.1)%) and insulin (23.8 (SD 18.7)%) concentrations. There were no significant changes in HDL-cholesterol or apo A-I. These results indicate that replacing part of the daily protein intake with soya protein has a beneficial effect on atherogenic lipids and favourably affects lipoprotein metabolism in hypercholesterolaemic patients undergoing haemodialysis.

Original languageEnglish
Pages (from-to)366-371
Number of pages6
JournalBritish Journal of Nutrition
Volume95
Issue number2
DOIs
Publication statusPublished - Feb 2006

Fingerprint

Lipoproteins
Renal Dialysis
Blood Proteins
Lipids
Proteins
Cholesterol
Breakfast
Milk Proteins
Apolipoprotein A-I
Beverages
Controlled Clinical Trials
Apolipoproteins B
LDL Cholesterol
HDL Cholesterol
Dialysis
Placebos
Clinical Trials
Insulin
Kidney

Keywords

  • Haemodialysis
  • Hypercholesterolaemia
  • Lipoproteins
  • Soya protein

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Effect of soya protein on serum lipid profile and lipoprotein concentrations in patients undergoing hypercholesterolaemic haemodialysis. / Chen, Shu Tzu; Chen, Jiun-Rong; Yang, Chwei Shiun; Peng, Sheng Jeng; Feng, Shyang H.

In: British Journal of Nutrition, Vol. 95, No. 2, 02.2006, p. 366-371.

Research output: Contribution to journalArticle

@article{1fa8223d5b884bc3a6747ee62ea4efa0,
title = "Effect of soya protein on serum lipid profile and lipoprotein concentrations in patients undergoing hypercholesterolaemic haemodialysis",
abstract = "Clinical trials have shown that soya protein reduces the concentrations of some atherogenic lipids in subjects with normal renal function. The present study examined the effects of soya protein on serum lipid concentrations and lipoprotein metabolism in patients on hypercholesterolaemic haemodialysis. Twenty-six hypercholesterolaemic (total cholesterol ≥ 6.21 mmol/l) patients on haemodialysis were studied in a randomized, double-blind, placebo-controlled clinical trial. After a 4-week run-in phase, the subjects were randomly assigned to two groups. Isolated soya protein or milk protein 30g was consumed daily as a beverage at breakfast or post-dialysis for 12 weeks. Soya protein substitution resulted in significant reductions in total cholesterol (17.2 (SD 8.9){\%}), LDL-cholesterol (15.3 (SD 12.5){\%}), apo B (14.6 (SD 12.1){\%}) and insulin (23.8 (SD 18.7){\%}) concentrations. There were no significant changes in HDL-cholesterol or apo A-I. These results indicate that replacing part of the daily protein intake with soya protein has a beneficial effect on atherogenic lipids and favourably affects lipoprotein metabolism in hypercholesterolaemic patients undergoing haemodialysis.",
keywords = "Haemodialysis, Hypercholesterolaemia, Lipoproteins, Soya protein",
author = "Chen, {Shu Tzu} and Jiun-Rong Chen and Yang, {Chwei Shiun} and Peng, {Sheng Jeng} and Feng, {Shyang H.}",
year = "2006",
month = "2",
doi = "10.1079/BJN20051646",
language = "English",
volume = "95",
pages = "366--371",
journal = "British Journal of Nutrition",
issn = "0007-1145",
publisher = "Cambridge University Press",
number = "2",

}

TY - JOUR

T1 - Effect of soya protein on serum lipid profile and lipoprotein concentrations in patients undergoing hypercholesterolaemic haemodialysis

AU - Chen, Shu Tzu

AU - Chen, Jiun-Rong

AU - Yang, Chwei Shiun

AU - Peng, Sheng Jeng

AU - Feng, Shyang H.

PY - 2006/2

Y1 - 2006/2

N2 - Clinical trials have shown that soya protein reduces the concentrations of some atherogenic lipids in subjects with normal renal function. The present study examined the effects of soya protein on serum lipid concentrations and lipoprotein metabolism in patients on hypercholesterolaemic haemodialysis. Twenty-six hypercholesterolaemic (total cholesterol ≥ 6.21 mmol/l) patients on haemodialysis were studied in a randomized, double-blind, placebo-controlled clinical trial. After a 4-week run-in phase, the subjects were randomly assigned to two groups. Isolated soya protein or milk protein 30g was consumed daily as a beverage at breakfast or post-dialysis for 12 weeks. Soya protein substitution resulted in significant reductions in total cholesterol (17.2 (SD 8.9)%), LDL-cholesterol (15.3 (SD 12.5)%), apo B (14.6 (SD 12.1)%) and insulin (23.8 (SD 18.7)%) concentrations. There were no significant changes in HDL-cholesterol or apo A-I. These results indicate that replacing part of the daily protein intake with soya protein has a beneficial effect on atherogenic lipids and favourably affects lipoprotein metabolism in hypercholesterolaemic patients undergoing haemodialysis.

AB - Clinical trials have shown that soya protein reduces the concentrations of some atherogenic lipids in subjects with normal renal function. The present study examined the effects of soya protein on serum lipid concentrations and lipoprotein metabolism in patients on hypercholesterolaemic haemodialysis. Twenty-six hypercholesterolaemic (total cholesterol ≥ 6.21 mmol/l) patients on haemodialysis were studied in a randomized, double-blind, placebo-controlled clinical trial. After a 4-week run-in phase, the subjects were randomly assigned to two groups. Isolated soya protein or milk protein 30g was consumed daily as a beverage at breakfast or post-dialysis for 12 weeks. Soya protein substitution resulted in significant reductions in total cholesterol (17.2 (SD 8.9)%), LDL-cholesterol (15.3 (SD 12.5)%), apo B (14.6 (SD 12.1)%) and insulin (23.8 (SD 18.7)%) concentrations. There were no significant changes in HDL-cholesterol or apo A-I. These results indicate that replacing part of the daily protein intake with soya protein has a beneficial effect on atherogenic lipids and favourably affects lipoprotein metabolism in hypercholesterolaemic patients undergoing haemodialysis.

KW - Haemodialysis

KW - Hypercholesterolaemia

KW - Lipoproteins

KW - Soya protein

UR - http://www.scopus.com/inward/record.url?scp=33644897863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644897863&partnerID=8YFLogxK

U2 - 10.1079/BJN20051646

DO - 10.1079/BJN20051646

M3 - Article

C2 - 16469155

AN - SCOPUS:33644897863

VL - 95

SP - 366

EP - 371

JO - British Journal of Nutrition

JF - British Journal of Nutrition

SN - 0007-1145

IS - 2

ER -